---
title: "生物製藥公司 Parabilis Medicines 申請在美國進行首次公開募股"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/286972753.md"
description: "生物製藥公司 Parabilis Medicines 已在美國提交了首次公開募股（IPO）申請，計劃將部分收益用於開發其藥物管線。這一舉措是在 Cerebras Systems 等公司成功上市後，投資者對新上市公司的興趣重新升温之際進行的"
datetime: "2026-05-19T22:23:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286972753.md)
  - [en](https://longbridge.com/en/news/286972753.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286972753.md)
---

# 生物製藥公司 Parabilis Medicines 申請在美國進行首次公開募股

May 19 (Reuters) - Parabilis Medicines on Tuesday filed for an initial public offering in the United States, according to a regulatory filing, and said it intends to use part of the proceeds to support the development of its drug pipeline. The IPO comes as investor appetite for new listings has improved following strong market debuts by companies such as AI chipmaker Cerebras Systems and

### 相關股票

- [CBRS.US](https://longbridge.com/zh-HK/quote/CBRS.US.md)

## 相關資訊與研究

- [AI 晶片新星 Cerebras IPO 倒數  估值衝 564 億美元](https://longbridge.com/zh-HK/news/286335836.md)
- [美股與油市挑戰加劇：Cerebras 上市與中美會談影響全球經濟佈局](https://longbridge.com/zh-HK/news/286347776.md)
- [維權投資者 Elliott 在醫療科技公司 Bio-Rad 建立「大量」持股](https://longbridge.com/zh-HK/news/286696875.md)
- [〈新股 IPO〉輝達要緊張了？AI 晶片新秀 Cerebras 掛牌首日飆近 9 成](https://longbridge.com/zh-HK/news/286449693.md)
- [今年最大 IPO 誕生！Cerebras 募資 55.5 億美元 市場瘋搶輝達以外 AI 新標的](https://longbridge.com/zh-HK/news/286341387.md)